Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
17 hedge funds and large institutions have $3.62M invested in Nemaura Medical, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 15 closing their positions.
9% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $956K
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
41% less funds holding
Funds holding: 29 → 17 (-12)
66% less capital invested
Capital invested by funds: $10.8M → $3.62M (-$7.19M)
80% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$415K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$170K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$162K |
| 4 |
MFG
Magnus Financial Group
New York
|
+$90.8K |
| 5 |
AIP
ARS Investment Partners
New York
|
+$69.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$2.8M |
| 2 |
Millennium Management
New York
|
-$651K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$650K |
| 4 |
E
Ergoteles
New York
|
-$298K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$269K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CG
26
Cutler Group
San Francisco,
California
| – | -$27.4K | -3,801 | Closed |
|
27
JP Morgan Chase
New York
| – | -$23.5K | -3,260 | -100% |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| – | -$21K | -2,035 | Closed |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$19K | -1,870 | Closed |
|
30
New York State Common Retirement Fund
Albany,
New York
| – | -$1K | -61 | Closed |
|
NMRD Hedge Fund Activity: Q3 2021 in Review
17 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q3 2021, worth a combined $3.62M — down 66% from $10.8M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of NMRD and 3 opened new positions — a net loss of 12 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $415K. The largest seller was Russell Investments Group, exiting entirely with an estimated $2.8M sold.
- 17 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q3 2021, down from 29 in Q2 2021.
- Funds reported $3.62M of Nemaura Medical, Inc. Common Stock stock for Q3 2021, down 66% quarter-over-quarter.
- 3 funds opened new Nemaura Medical, Inc. Common Stock positions in Q3 2021 and 15 closed out, a net change of -12 holders.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q3 2021 was Renaissance Technologies, an estimated $415K added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q3 2021 was Russell Investments Group, an estimated $2.8M sold.
Based on aggregated 13F filings for Q3 2021.